Table 3.
Non-cancer and cancer risk assessment of adults and children under different exposure routes.
| Oral ingestion | Respiratory inhalation | Dermal contact | ||||||
|---|---|---|---|---|---|---|---|---|
| Children | Adult | Children | Adult | Children | Adult | Children | Adult | |
| Hazard quotient and hazard index of each PTE | HI | |||||||
| As | 9.07E−01 | 1.27E−01 | 2.50E−05 | 1.40E−05 | 6.98E−08 | 1.64E−08 | 9.07E−01 | 1.27E−01 |
| Cd | 3.82E−03 | 5.35E−04 | 1.05E−05 | 5.90E−06 | 2.86E−06 | 6.74E−07 | 3.84E−03 | 5.42E−04 |
| Cr | 4.91E+00 | 6.88E−01 | 1.42E−02 | 7.96E−03 | 1.43E−06 | 3.37E−07 | 4.93E+00 | 6.96E−01 |
| Cu | 2.62E−02 | 3.67E−03 | 7.02E−07 | 3.93E−07 | 1.06E−07 | 2.49E−08 | 2.62E−02 | 3.67E−03 |
| Mn | 5.42E−02 | 7.58E−03 | 4.18E−03 | 2.34E−03 | 2.18E−06 | 5.13E−07 | 5.84E−02 | 9.93E−03 |
| Ni | 1.71E−01 | 2.39E−02 | 4.57E−06 | 2.56E−06 | 1.06E−07 | 2.49E−08 | 1.71E−01 | 2.39E−02 |
| Pb | 1.17E+00 | 1.64E−01 | 3.23E−05 | 1.81E−05 | 1.91E−07 | 4.49E−08 | 1.17E+00 | 1.64E−01 |
| Zn | 5.53E−03 | 7.74E−04 | 1.52E−07 | 8.54E−08 | 1.43E−07 | 3.37E−08 | 5.53E−03 | 7.74E−04 |
| Ba | 3.71E−02 | 5.19E−03 | 1.02E−06 | 5.72E−07 | 2.86E−08 | 6.74E−09 | 3.71E−02 | 5.19E−03 |
| THI | – | – | – | – | – | – | 7.31E+00 | 1.03E+00 |
| Cancer risk of each PTE | CR | |||||||
| As | 3.50E−05 | 2.12E−05 | 9.71E−09 | 2.36E−08 | 2.69E-12 | 2.75E-12 | 3.50E−05 | 2.12E−05 |
| Cd | 1.67E−07 | 1.01E−07 | 5.69E-11 | 1.38E-10 | 4.91E-11 | 5.00E-11 | 1.67E−07 | 1.02E−07 |
| Cr | 6.32E−04 | 3.83E−04 | 1.46E−06 | 3.55E−06 | 1.47E-10 | 1.50E-10 | 6.33E−04 | 3.87E−04 |
| Ni | 2.46E−04 | 1.49E−04 | – | – | – | – | 2.46E−04 | 1.49E−04 |
| Pb | 2.99E−05 | 1.81E−05 | – | – | – | – | 2.99E−05 | 1.81E−05 |
| TCRI | – | – | – | – | – | – | 9.44E−04 | 5.75E−04 |